Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests as well as the accuracy of drug delivery for infectious diseases and oncology.
Who is novosanis
Latest news
Novosanis launches volume variants of Colli-Pee® offering new applications in urine testing
8/10/2019
We are excited to announce the launch of volume variants of Colli-Pee® , our innovative urine-capturing device offering additional applications in the fields of infectious disease, uro-oncology and more.
Latest blogpost
Upcoming event
Circulating Biomarkers, Exosomes & Liquid Biopsy Europe 2019
Rotterdam, Netherlands
Novosanis will be present at the Circulating Biomarkers, Exosomes & Liquid Biopsy Europe 2019 conference in Rotterdam, Netherlands.
Events
Regulatory
Team
News